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Abstract
Objective. The objective of this study was to describe the mechanism of healing of osteochondral defects of the distal femur
in the sheep, a commonly used translational model. Information on the healing mechanism be useful to inform the design
of tissue engineering devices for joint surface defect repair. Design. A retrospective study was conducted examining 7-mm
diameter osteochondral defects made in the distal medial femoral condyle of 40 adult female sheep, comprising control
animals from 3 separate structures. The healing of the defects was studied at post mortem at up to 26 weeks. Results.
Osteochondral defects of the distal femur of the sheep heal through endochondral ossification as evidenced by chondrocyte
hypertrophy and type X collagen expression. Neocartilage is first formed adjacent to damaged cartilage and then streams
over the damaged underlying bone before filling the defect from the base upward. No intramembranous ossification or
isolated mesenchymal stem cell aggregates were detected in the healing tissue. No osseous hypertrophy was detected
in the defects. Conclusions. Osteochondral defects of the medial femoral condyle of the sheep heal via endochondral
ossification, with neocartilage first appearing adjacent to damaged cartilage. Unlike the mechanism of healing in fracture
repair, neocartilage is eventually formed directly onto damaged bone. There was most variability between animals between
8 and 12 weeks postsurgery. These results should be considered when designing devices to promote defect healing.
Keywords
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Introduction
Synovial joint surface defects are important causes of osteoarthritis (OA), the most prevalent disease of synovial joints,
afflicting humans and animals and causing a huge health
care, welfare, and economic burden.1 A considerable
amount of research time and effort is directed at devising
tissue engineering strategies to enhance joint surface defect
healing, including using cell-based therapies, tissue engineering solutions, and small molecule treatment. However,
the development of optimal repair strategies is hampered by
a lack of full understanding of the underlying mechanisms
by which joint surface defects heal. While a number of studies exist in rodents and small animals, relatively little is
known of the healing mechanism of osteochondral defects
in large animals and, by inference, in man.
Joint surface defects occur either in the cartilage (“chondral” defects) or develop in the cartilage and underlying
bone (“osteochondral” defects). Osteochondral defects
have healing capacity if they are small and are believed to
heal by recruiting nondifferentiated bone marrow–derived
stromal/stem cells contained in the bone marrow into the
damaged site. In contrast, chondral defects have a poor

intrinsic healing capacity. Treatment strategies to heal chondral defects often utilize the bone marrow–derived stromal/
stem cell population by accessing the bone marrow through
microfracture techniques, which provide cost-effective and
functional healing in many cases.2-4 The precise contribution of the stromal stem cell population to the healing of
osteochondral defects, however, is not known, although
they may have both a direct and/or indirect (modulatory)
effect on the repair tissue.
The mechanism by which osteochondral defects heal
has been described in a number of animals, with most work
being performed in rabbits. Shapiro et al5. described the
sequence of healing in 3-mm diameter osteochondral
defects of the femoral trochlea including an initial fibrin
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repair, mesenchymal cell recruitment, cartilage formation
starting adjacent to the damaged cartilage, and subsequent
bone formation. Other work, in larger animals, has
described cartilage formation adjacent to the residual damaged cartilage. It has been shown that a number of different
parameters can affect both the efficiency of healing and
possibly the mechanism of healing, including the position
of the defect in the knee joint (with both anatomical considerations6,7 and biomechanical differences8 being important), the size and depth of the defect,9 and the age of the
animal.10
The sheep is a commonly used translational model for
evaluating efficacy of potential treatments for osteochondral defects7,11,12; however, the mechanisms by which osteochondral defects heal in sheep are not described. The aim of
this study was to describe the temporal sequence of healing
of 7-mm diameter osteochondral defects of the distal femur
in the sheep in order to provide key information on those
processes that are potential targets for therapy.

Materials and Methods
This study received approval from both the Animal Welfare
and Ethical Review Board, Cambridge University, and the
UK Home Office (Project Licence Number 70/8165).

Animals
Forty skeletally mature female Welsh Mountain Sheep
(mean age 3.2 ± 0.8 years) were included in the study, representing the control (untreated empty defect) animals from
3 experiments conducted in our laboratory performed by
the same surgical team. The experiments were conducted
12 months apart in 3 cohorts, with the surgical component
of the work carried out in the same calendar month each
year. The feed, husbandry, and location of the sheep was the
same in all animals. The animals were all obtained from the
same supplier source.

Animal Anesthesia, Preparation, and Surgical
Technique
General anesthesia was induced with an injection of thiopentone (3 mg/kg) and maintenance achieved via inhalational anesthetic of a mixture of isofluorane, nitrous oxide,
and oxygen. Perioperative analgesia was provided by preoperative intramuscular carprofen. Antibiotic prophylaxis
was given via intramuscular procaine penicillin. The basic
surgical procedure was identical for all subjects and performed under strict asepsis. Each stifle was physically
examined for any abnormalities while anesthetized. If any
gross instability or pathology was found, the animal was
excluded from participation within the study.

The animal was placed in a dorsal recumbency position
and, following surgical preparation, the left stifle joint
opened via a parapatellar approach. Following patella subluxation, a full-thickness 7 mm diameter × 6 mm deep
osteochondral defect was created in the medial femoral
condyle using a hand drill. The joint was closed in a standard fashion. No splints, casts, or immobilization techniques were used in any animal.
Postoperatively, animals were allowed to fully weight
bear, but kept in small pens for 48 hours to reduce ambulation. All animals were housed indoors for the remaining
study period in large pens or outdoor in fields, both of which
permitted normal ambulation. Animals were killed with an
overdose of injectable anesthetic at 1, 2, 4, 8, 12, 18, and 26
weeks postsurgery.

Histology
Specimens were decalcified in formic acid/sodium citrate
over 4 weeks. Following complete decalcification, the specimens were dehydrated through a series of ethanol exchanges
of increasing concentrations, cleared in xylene, and then
embedded in paraffin wax. Sections of 8-µm thickness were
made through the central portion of the defect. Sections were
stained with toluidine blue and/or Safranin O/Fast Green. A
semiquantitative histological analysis was performed as
described by Mainil-Varlet et al.,13 based on a semiquantitative scoring system originally described by O’Driscoll et al.14
(Table 1). This scoring system has a maximum of 34 points
and is suitable for demonstrating longitudinal healing of
osteochondral defects in large animal species.6 Scoring was
carried out blindly by one observer (FH).

Immunohistochemistry
Immunohistochemistry was performed as described previously.11 The following primary antibodies were used in this
study: polyclonal rabbit anti type X collagen (ab58632,
Abcam, UK, 1 in 200 dilution) and monoclonal mouse antiPCNA (DAKO, UK). Type X collagen immunostaining was
detected with a FITC-conjugated secondary anti-rabbit secondary antibody (Sigma) and PCNA immunostaining was
detected with a TRITC-conjugated secondary anti-mouse
antibody (Sigma). Normal species-specific serum was used
as a control for each antibody.

Results
Weeks 1 to 2: The Osteochondral Defect Is
Infilled with Fibrous Tissue
At weeks 1 and 2 after injury, the defect site had filled with
blood clot and fibrous tissue. The fibrous tissue was organized
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Table 1. Parameters included in semiquantitative histological
analysis.
Category
Tissue
morphology

Matrix staining

Structural
integrity

Chondrocyte
clustering
Formation of
tidemark

Subchondral
bone
formation
Architecture of
the surface

Filling of the
defect

Lateral
integration

Basal
integration

Inflammation

Characteristic

Points

Mostly hyaline cartilage
Mostly fibrocartilage
Mostly noncartilage
Noncartilage only
Normal or near normal
Moderate
Slight
None
Normal
Beginning of columnar organization
No organization
Cysts or disruptions
Severe disintegration
No clusters
<25% of the cells
25% to 100%
Complete
76% to 90%
50% to 75%
25% to 49%
<25%
Good
Slight
No formation
Normal
Slight fibrillation or irregularity
Moderate fibrillation or irregularity
Severe fibrillation or disruption
91% to 100%
76% to 90%
51% to 75%
26% to 50%
<25%
Bonded at both ends of graft
Bonded at one end/partially
bonded at both sides
Not bonded
91% to 100%
70% to 90%
50% to 70%
<50%
No inflammation
Slight inflammation
Strong inflammation

3
2
1
0
3
2
1
0
4
3
2
1
0
2
1
0
4
3
2
1
0
2
1
0
3
2
1
0
4
3
2
1
0
2
1
0
3
2
1
0
4
2
0

with a visible surface layer. At the edge of the damaged articular cartilage there was a loss of normal architecture (Fig. 1A).
The normal chondrocyte arrangement was replaced with a
zone of multicellular chondrocyte “clusters” associated with a
zone of proteoglycan loss as detected by a reduction in toluidine blue staining at the site.

Weeks 4 to 8: Chondrocytes Form Adjacent
to the Edge of Damaged Cartilage and Bone
Formation Occurs through Endochondral
Ossification
Between weeks 4 and 8, neocartilage was evident at the top
edges of the defect immediately adjacent to the edge of the
remaining cartilage and the cartilage clusters (Figs. 1B and
2). The cells within the chondrocyte clusters were positively
stained for PCNA immunoreactivity indicating active
cycling. Close examination of the tissue suggested that
these new chondrocytes derived primarily from differentiation of the fibrous tissue clot adjacent to the damaged cartilage. However, there was some suggestion that chondrocytes
at the edges of the damaged cartilage were contributing to
repair as the orientation of the chondrocytes at the edges of
the damaged cartilage was toward the neocartilage rather
than the articular surface (Fig. 2).
From week 4 onwards, the area in which chondrocytes
were seen was now extending toward the base of the defect
following the edge of the bone. In defects of increasing age
these are covered more of the base of the lesion until they
joined with the chondrocytes arising from the opposite side
of the lesion by approximately 8 weeks postinjury, effectively lining the exposed bone edges of the defect (Fig. 3).
Chondrocytes adjacent to the exposed bone edge were
observed to be larger and more rounded than the new chondrocytes that were arising toward the top of the defect with
a morphology similar to hypertrophic chondrocytes.
Positive type X collagen staining in these larger chondrocytes confirmed their identity as hypertrophic chondrocytes
(Fig. 3). No evidence of intramembranous ossification was
detected in any of the sections studied, nor were any cartilage “islands” observed within the fibrous tissue away from
the damaged bone edges.

Weeks 8 to 12: Bone Formation Occurs through
Endochondral Ossification from the Base and
Edges of the Lesion
From week 8 onwards, the healing process continued via a
process of endochondral ossification with a gradual increase
in the amount of cartilage within the defect (Fig. 4). The cartilage formed within the healing tissue did not show any recognizable columnar structure at 8 weeks, but by 12 weeks,
the chondrocytes were beginning to become more structured
at the edge of the lesion close to the intact cartilage.

Week 18: New Bone Formation Continues and
Cartilage Is Removed
At week 18, new bone had been formed at the edges and
base of the defect: at this time point a characteristic “v”
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7.3 ± 1.3, and 8.6 ± 1.7, respectively, with the majority of the
scoring coming from the integration of the infill material with
the intact cartilage edges and the underlying bone. At 8 weeks
of healing the mean score had risen to a mean of 14.6 ± 1.7,
increasing through a mean of 16.3 ± 2.5 at 12 weeks, a mean
of 25 ± 0 at 18 weeks, and ending at 26 weeks with a mean of
29.6 ± 0.63. Between 4 and 8 weeks there was increased
scoring for tissue infill and surface integrity and then increasing scoring for morphology, structure, and matrix staining in
the later time points. The tidemark was not fully restored at
26 weeks in any animal.

Discussion

Figure 1. Toluidine blue stained histology sections of the
defect edge at (A) 1 week and (B) 4 weeks postinjury. In both
A and B there is loss of proteoglycan at the cartilage edge and
a loss of the normal architecture of the cartilage. Chondrocyte
clusters are seen in B. In A, fibrous tissue fills the defect with a
defined surface layer. In B the fibrous tissue filling the lesion is
being replaced by rounded chondrocytes. c = cartilage edge; f
= fibrous tissue in defect; b = bone; s = surface of tissue infill in
defect; cc = calcified cartilage; ch = chondrocytes in defect; bv =
blood vessel. Bar = 750 µm.

shaped healing lesion was observed (Fig. 4). There was evidence of tidemark reformation in the newly formed cartilage only at the edges of the defect and the chondrocytes
within this newly formed cartilage had organized into an
approximately columnar structure.

Week 26: Healing Is Nearly Complete
Healing was very close to completion at 26 weeks (mean
histological score 29.6/34). At 26 weeks the defect had been
filled in with cartilage and bone. The cartilage/bone junction was positioned at the correct anatomical site within the
cartilage/bone unit; however, the tidemark was not completely reformed in any animal. Within the subchondral
bone underneath the newly formed cartilage, there were
numerous cartilage remnants remaining that would require
further resorption and remodeling in future. No evidence of
osseous hypertrophy was found in any sample studied.

Semiquantitative Analysis
A scoring system suitable for scoring the healing of experimental large animal osteochondral defects was used. This
scoring system demonstrated that an increase in score correlated with the age of the lesion in these medial femoral condyle lesions (Fig. 5). At 1, 2, and 4 weeks of healing the mean
healing score (out of a possible total of 34) was 7.6 ± 0.94,

Healing of joint surface defects remains a clinical challenge
with significant research endeavor directed at optimizing
treatment strategies. Understanding the mechanisms behind
normal healing is vital to inform therapy selection and
experimental design. In this study, we examined the temporal sequence of healing within an osteochondral defect
experimentally created in the medial femoral condyle in the
sheep and demonstrated that healing of the defect occurs via
endochondral ossification. The defect size in this study was
7 mm diameter, which was nearly fully healed within 26
weeks at this anatomical site (cartilage formed in the appropriate place but with some remodeling of subchondral bone
and tidemark formation still occurring). These data indicate
that a 7-mm osteochondral defect in the medial femoral
condyle is able to achieve spontaneous repair and is thus
considered as below a “critical size”, that is, a defect of a
size that cannot spontaneously heal.15
Whether or not an experimental defect is small enough
to achieve spontaneous repair is extremely important in the
evaluation of therapeutic interventions. Various factors play
a role in determining whether a defect can spontaneously
repair, including the anatomical site of the lesion in the joint
(medial femoral condyle lesions are reported to heal more
poorly than comparable lesions in the trochlea in the sheep7
but better in the mini-pig6). In the goat, it has been reported
that a 6-mm diameter defect in the medial femoral condyle
does not undergo spontaneous repair16; however, in other
studies in sheep an 8.3-mm diameter osteochondral defect
in the medial femoral condyle did not heal after 6 months,9
suggesting that a defect of approximately 8 mm is the size
below which spontaneous healing occurs in the medial femoral condyle of adult sheep at 6 months.
These results show that ovine osteochondral healing
occurs through a defined sequence of events. Initially the
lesion is filled with a hematoma that then rapidly remodels
to form a fibrous clot. The first sign of organ-specific tissue
is the formation of neocartilage adjacent to the damaged
edges of the cartilage. At this stage in the healing process,
there was a very similar histological appearance to the healing defects and similar histological scoring in different
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Figure 2. Hematoxylin-eosin stained histology sections of the defect edge at 8 weeks postinjury. (A) Low-power view to show
structure of the edge of the defect, Bar = 400microns. (B) Higher power view of box region of A to show presence of multicellular
chondrocyte clusters and an apparent recruitment of chondrocytes derived from residual cartilage tissue into the new chondrocytes
being produced in the fibrous tissue infill. Bar = 400microns. (C) Higher power view of box region of B stained with anti-PCNA
antibody with a TRITC-labelled secondary antibody. PCNA activity is shown in red. Bar = 250 µm.

Figure 3. Toluidine blue stained histology section of the defect at 8 weeks postinjury. (A) Low-power view to show structure of the
edge (red arrows) and base of the defect (black defect). Large rounded cells that are stained more intensely with the toluidine blue
can be seen lining the edges and base of the defect (white arrows). Bar = 500 µm. (B) Higher power view of box region of A to show
the appearance of the large rounded cells. Bar = 750 µm. (C) Higher power view of box region of B stained with anti-type C collagen
antibody with a FITC-labelled secondary antibody. Type X collagen is shown in green, confirming the identity of these large rounded
cells adjacent to the edge and base of the defect as hypertrophic chondrocytes. Bar = 750 µm. c = cartilage edge; f = fibrous tissue in
defect; b = bone; s = surface of tissue infill in defect; hc = hypertrophic chondrocytes; bv = blood vessel.

animals at the same time postsurgery. This neocartilage is
then observed, over time, to stream down the edges of the
defect supported by the underlying bone, coalescing at the
base of the lesion. New bone is produced circumferentially

on the edges and base of the lesion via the process of endochondral ossification, as evidenced by the characteristic
hypertrophic morphology of the chondrocytes and the
expression of type X collagen. In this sheep osteochondral

Lydon et al.
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Figure 4. Safranin O stained histology sections of defects at 12 weeks (A), 18 weeks (B), and 26 weeks (C) postinjury. Cartilage is
stained in red. At 12 weeks a cartilage plug is filling the defect. At 18 weeks the cartilage plug has reduced in size as the base and sides
of the defect become filled in. By 26weeks the cartilage plug has been replaced by bone and the cartilage remaining at the defect site is
of a similar depth to the original cartilage. Cartilage remnants are seen within the newly formed bone. Bar = 200 µm.

Figure 5. A semi-quantitative analysis was performed on
the histological sections from the medial femoral condyle. An
increased score correlated with the age of the lesion.

repair process, no evidence of mesenchymal stem cell
(MSC) cell condensation was detected in the center of the
lesion as had been reported in the rabbit.5 As healing progressed to weeks 8 and 12, there was a wider difference
between individual animals, at 12 weeks the International
Cartilage Repair Society scoring varying between 13/34
(38% “healed”) and 19/34 (56% “healed”), that is, an 18%
variation in healing scores, primarily due to differences in
the maturation state of the new cartilage formed. However,
by 18 weeks and then at 26 weeks there was a marked
reduction in variability, with all animals scoring similarly.
These results indicate that, at 26 weeks postsurgery animals
have a similar histological appearance in 7 mm defects in
the medial femoral condyle. The increased variation
between animals at 8 and 12 weeks postsurgery recorded in
this study suggests that the interpretation of results of
experiments to document osteochondral healing in the
medial femoral condyle of sheep with an in-life phase of 8

to 12 weeks is likely to be complicated by individual differences and, as such, are not optimal for such investigations.
The origin of the neocartilage and the cartilage that then
covers the exposed bone surface is not known. The neocartilage originates at the junction between the fibrous clot
and the damaged cartilage and could arise either from (a)
the damaged cartilage edge (via activation of cartilage progenitor cells17) or by (b) recruitment and differentiation of
MSC (released from the bone marrow). PCNA labelling
indicated that the cells within the fibrous clot and the chondrocyte clusters in the damaged cartilage edge are actively
cycling. Shapiro et al.5 showed, using longitudinal tritiated
thymidine labelling, that there was significant labelling of
undifferentiated cells within the fibrous clot, as well as in
the damaged cartilage, and concluded that the undifferentiated cells primarily contributed to the regeneration of the
defect. However, some histological sections in this study
do appear to show a possible contribution of damaged cartilage to new cartilage production and further studies are
required to investigate the precise contribution of the chondrocytes and undifferentiated cells in large animal osteochondral healing.
Whatever proves to be the source of the neocartilage,
this study demonstrates the importance of the damaged tissue in directing healing. Neocartilage is initially formed
adjacent to the damaged cartilage, indicating that, if not
directly contributing to the neocartilage production, the
damaged cartilage is providing an appropriate structural
support for neocartilage production and/or secreting local
trophic factors to induce differentiation of undifferentiated
cells into cartilage. It is known that adult articular cartilage
is a rich source of morphogenic signals upon injury18,19 and
cartilage damage induces activation of factors including
bone morphogeneic proteins (BMP) and Wnt signaling
proteins within damaged cartilage,20,21 and released into
the local environment, for example, fibroblastic growth
factors (FGF).22
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The importance of the damaged tissue in directing repair
is also apparent in the progression of cartilage formation as
it lines the edge of the damaged bone prior to infilling the
defect. This observation that endochondral ossification
occurs upon the damaged bone is unlike the situation during
fracture repair, where the cartilage callus is laid down
through endochondral ossification on the intact periosteal
bone surface rather than on the fractured bone ends,23 demonstrating that osteochondral repair, in these animals at this
anatomical site, occurs in a dissimilar repair environment to
that which occurs in fracture repair.
As previously discussed regarding the role of damaged
cartilage in neocartilage formation, whether the bone is acting as a physical support and/or as a producer of trophic
mediators for chondrogenesis is not known. Differentiation
of MSC into chondrocytes is enhanced by increased
load24,25: we could hypothesize that the junction between
fibrous tissue and bone experiences increased load relative
to elsewhere in the fibrous tissue within the defect and that
the MSC in this area are being influenced by this load differential. The repair tissue/bone interface also represents an
area of altered vascularity and oxygen tension within the
damaged tissue, and it has been demonstrated, by many
authors, that these variables, among many others, can affect
cartilage repair processes.26-28 Clearly, further studies are
required to fully characterize the role of bone in osteochondral repair.
There have been few studies that describe longitudinal
observations of healing in large animal models, and to the
authors’ knowledge, there have been no previous studies of
longitudinal healing in the medial femoral condyle of the
sheep. Jackson et al.15 demonstrated, over 52 weeks in a
goat model, that a 6-mm diameter osteochondral defect fails
to heal and that progressive, resorption of the defect and
subsequent collapse of the defect occur. As observed in this
study, clustering of chondrocytes at the edges of the damaged cartilage was noted but endochondral ossification (as
determined by toluidine blue staining) was only detected at
the base of the lesion. Gotterbarn et al.29 reported that during healing of the medial aspect of the lateral trochlea ridge
in mini-pigs endochondral ossification and cartilage streaming was observed at the upper edges of the lesion only.
The results of this study show that endochondral ossification is the mechanism by which osteochondral defects
heal in the sheep. The quantitative analysis of the healing
shows that there is little variability in the initial stages of
healing between animals, but that variability is more marked
between 8 and 12 weeks of repair. However, by the end
point of this study, 26 weeks, the variability was reduced
and the appearance of the healing defects similar. In sheep,
unlike in laboratory animals such as mice, there are far
more genetic differences between individuals. In this study,
we have sought to eliminate individual differences as much
as is practically possible, using female sheep of a similar
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age of the same breed from the same supplier; however,
these studies were conducted over a 3-year period (drawn
from the control animals of different studies) and the results
may be confounded by individual variations.
This finding provides information that may assist the
design of tissue engineering strategies to heal osteochondral
defects. However, this finding also poses a potential
dilemma for strategies that have been used to reduce the
deleterious osseous overgrowth that can occur during joint
surface defect repair.30,31 On the basis of the findings
reported here, future regenerative therapies should be
directed at maintaining chondrocyte phenotype in the chondral layer of the defect once the subchondral bone plate is
restored and strategies to inhibit endochondral ossification
should be used cautiously.
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